- Home
- HOLX
HOLX
Hologic Inc.
as of 12-03-2025 3:42pm EST
$75.06
+$0.24
+0.31%
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Chart Type:
Time Range:
| Founded: | 1985 | Country: | United States |
| Employees: | N/A | City: | MARLBOROUGH |
| Market Cap: | 16.6B | IPO Year: | 1990 |
| Target Price: | $79.64 | AVG Volume (30 days): | 3.1M |
| Analyst Decision: | Hold | Number of Analysts: | 15 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 2.49 | EPS Growth: | -25.00 |
| 52 Week Low/High: | $51.90 - $80.31 | Next Earning Date: | 11-03-2025 |
| Revenue: | $4,100,500,000 | Revenue Growth: | 1.74% |
| Revenue Growth (this year): | 6.69% | Revenue Growth (next year): | 5.74% |
AI-Powered HOLX Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 70.67%
70.67%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Hologic Inc. (HOLX)
Stamoulis Christiana
Sell
Director
HOLX Oct 20, 2025
Avg Cost/Share
$73.07
Shares
7,402
Total Value
$540,864.14
Owned After
47,336
SEC Form 4
MACMILLAN STEPHEN P
Sell
Chairman, President and CEO
HOLX Sep 22, 2025
Avg Cost/Share
$66.83
Shares
138,358
Total Value
$9,266,117.92
Owned After
1,350,742
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Stamoulis Christiana | HOLX | Director | Oct 20, 2025 | Sell | $73.07 | 7,402 | $540,864.14 | 47,336 | |
| MACMILLAN STEPHEN P | HOLX | Chairman, President and CEO | Sep 22, 2025 | Sell | $66.83 | 138,358 | $9,266,117.92 | 1,350,742 |
Latest Hologic Inc. News
HOLX Breaking Stock News: Dive into HOLX Ticker-Specific Updates for Smart Investing
Zacks
HOLX vs. DGX: Which Healthcare Diagnostics Stock Is the Better Bet?
📊
AI Sentiment
Positive
7/10
Simply Wall St.
Is AI-Driven Imaging Innovation Changing the Investment Case for Hologic (HOLX)?
📊
AI Sentiment
Positive
7/10
Compare HOLX vs Leading Stocks
See how HOLX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "HOLX Hologic Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.